why choose us

First received: May 16, 2023

Clinical Trial: Efficacy and Safety Study of Moxidectin in Adults With Scabies

Study Status: Completed

Recruit Status: RECRUITING

Condition: Scabies

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies.

Brief Summary: Moxidectin is not approved to treat scabies in humans.The effective dose of moxidectin to treat scabies is not known.This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28.This study also aims to assess the safety of three strengths of single moxidectin doses in adults with scabies.

Read more